Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial

Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.7%
    Check dated 2025-05-08T13:51:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.7%
    Check dated 2025-05-01T06:18:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-04-24T00:59:44.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial related to ARGX-110 and acute myeloid leukemia, while adding new identifiers and collaborators.
    Difference
    18%
    Check dated 2025-04-16T20:33:10.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.9%
    Check dated 2025-04-09T14:19:03.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.5%
    Check dated 2025-04-02T00:14:12.000Z thumbnail image

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.